News and Analysis | Published:

Preclinical antibiotic pipeline gets a pick-me-up

Nature Reviews Drug Discovery volume 16, pages 741742 (2017) | Download Citation

CARB-X, a public–private partnership aimed at bolstering the antibiotic pipeline, funded a diverse set of 17 early-stage drug development projects in its first year.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

About this article

Publication history




  1. Search for Asher Mullard in:

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing